Completed OBSERVATIONAL NCT00168259

Evaluation of Interferon-gamma Responses to HCMV Infection in HIV Positive Individuals

Sponsor: Cellestis

Updated 10 times since 2017 Last updated: Jan 19, 2012 Started: Dec 31, 2004 Completion: Dec 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on CMV Infection and HIV Infection, this trial is completed. The trial is conducted by Cellestis and has accumulated 10 data snapshots since 2004. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

Change History

10 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2021 — Jul 2024 [monthly]

Completed
Jan 2021 — Dec 2021 [monthly]

Completed
Nov 2020 — Jan 2021 [monthly]

Completed

▶ Show 5 earlier versions

Jun 2018 — Nov 2020 [monthly]

Completed
May 2018 — Jun 2018 [monthly]

Completed
Apr 2018 — May 2018 [monthly]

Completed

Phase: NA → None
Aug 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Aug 2017 [monthly]

Completed NA

First recorded

Dec 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Cellestis
The Alfred

Data source: The Alfred

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Melbourne, Australia